SAB Biotherapeutics Revenue

Revenue (ttm)

n/a

Revenue Growth

n/a

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

Market Cap

267.05M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	-	-	-
Dec 31, 2024	1.32M	-916.58K	-40.94%
Dec 31, 2023	2.24M	-21.67M	-90.63%
Dec 31, 2022	23.90M	-36.97M	-60.73%
Dec 31, 2021	60.88M	5.64M	10.21%
Dec 31, 2020	55.24M	51.80M	1,504.91%
Dec 31, 2019	3.44M	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Cellectis	79.59M
Compugen	72.76M
Coherus Oncology	42.17M
C4 Therapeutics	35.95M
Zentalis Pharmaceuticals	26.87M
Alector	21.05M
Artiva Biotherapeutics	251.00K

Revenue Rankings

SABS News

1 day ago - SAB BIO Presents Additional Clinical and Mechanistic Data from SAB-142 Phase 1 Trial in Adult Patients with Established Autoimmune Type 1 Diabetes at IDS 2026 - GlobeNewsWire
5 weeks ago - SAB BIO Announces Closing of $85 Million Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire
5 weeks ago - SAB BIO Announces Pricing of $85 Million Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire
5 weeks ago - SAB BIO Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire
6 weeks ago - SAB BIO Announces Additional Phase 1 Data for SAB-142 in Adult Patients with Established Autoimmune Type 1 Diabetes - GlobeNewsWire
6 weeks ago - SAB BIO Reports Full Year 2025 Financial Results and Business Highlights - GlobeNewsWire
7 weeks ago - SAB BIO to Participate in Upcoming Investor Conferences - GlobeNewsWire
3 months ago - SAB BIO Strengthens Board of Directors with Appointment of New Chair and New Director - GlobeNewsWire

More News